Asthma Clinical Trial
Official title:
Improving Asthma Outcomes Through Spirometry Distance Learning
Spirometry is a recommended component of asthma diagnosis and treatment in the primary care
setting, yet few providers report its routine use for children with asthma.
Misclassification of asthma severity occurs when assessment is based on symptoms alone. This
misclassification can lead to inadequate treatment, increased morbidity, and increased
healthcare utilization/cost.
The goal of this study is to test the effectiveness of a distance learning quality
improvement program called Spirometry 360 developed by the interactive Medical Training
Resources (iMTR) group at the University of Washington Child Health Institute. The
Spirometry 360 program aims to improve care for children with asthma by enhancing provider
knowledge and self-efficacy related to the use and interpretation of office-based
spirometry.
The Spirometry 360 program includes:
1. "Spirometry Fundamentals™: A basic guide to lung function testing," a computer-based
training program that teaches primary care providers how to coach patients to produce
high-quality spirometry tests and accurately interpret spirometric data;
2. Spirometry Learning Lab: Case-based teaching of spirometry in practice guides test
administrators and interpreters through clinical examples in an interactive virtual
classroom setting. These sessions are led by expert clinical faculty and are archived
for future reference and review;
3. Spirometry Feedback: Tailored analysis of providers' spirometry testing sessions offers
monthly individualized feedback reports by clinical experts on spirometry tests
performed in the clinic.
This is a cluster randomized controlled trial to test the effectiveness of the Spirometry
360 program. The Spirometry 360 program will be provided to 25 primary care pediatric
practices from two practice-based research networks. A separate group of 25 matched control
practices recruited from these same networks will receive standard training from the
equipment vendor during the study and the Spirometry 360 training program at the end of the
study.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|